Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Astria Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 76 | 68 | −8 |
| Shares | 24.7M | 23.0M | −1.69M (−6.8%) |
| Value | $205.5M | $171.4M | −$34.0M (−16.6%) |
New holders (4)
Institutions that held Astria Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 19,530 | $145.7K | 0.00% |
| Jump Financial, LLC | 14,926 | $111.3K | 0.00% |
| AQR Capital Management LLC | 12,790 | $95.4K | 0.00% |
| Group One Trading, L.P. | 3,200 | $23.9K | 0.00% |
Sold out (12)
Institutions that held Astria Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cormorant Asset Management, LP | 1,000,000 | $8.33M |
| Opaleye Management Inc. | 305,000 | $2.54M |
| Millennium Management LLC | 276,672 | $2.30M |
| Two Sigma Advisers, LP | 133,034 | $1.11M |
| Two Sigma Investments, LP | 93,913 | $782.3K |
| Norges Bank | 32,300 | $269.1K |
| Samsara BioCapital, LLC | 25,000 | $208.3K |
| Franklin Resources Inc | 12,754 | $106.2K |
| Raymond James & Associates | 12,308 | $102.5K |
| Susquehanna International Group, LLP | 11,291 | $94.1K |
| Jane Street Group, LLC | 10,751 | $89.6K |
| Aquatic Capital Management LLC | 800 | $7.00K |